vs
Side-by-side financial comparison of GRIFFON CORP (GFF) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
GRIFFON CORP is the larger business by last-quarter revenue ($649.1M vs $384.8M, roughly 1.7× P3 Health Partners Inc.). GRIFFON CORP runs the higher net margin — 9.9% vs -19.6%, a 29.5% gap on every dollar of revenue. On growth, P3 Health Partners Inc. posted the faster year-over-year revenue change (3.8% vs 2.6%). Over the past eight quarters, P3 Health Partners Inc.'s revenue compounded faster (-0.5% CAGR vs -1.8%).
Griffon Corporation is a multinational conglomerate headquartered in New York City. It operates as a diversified management and holding company. The company has four subsidiaries: Ames True Temper, ClosetMaid, Clopay Building Products, and CornellCookson. Griffon has been publicly traded since 1961 and is listed on the New York Stock Exchange as a component stock of the S&P SmallCap 600, S&P Composite 1500, and Russell 2000 indices.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
GFF vs PIII — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $649.1M | $384.8M |
| Net Profit | $64.4M | $-75.5M |
| Gross Margin | 41.1% | — |
| Operating Margin | 17.5% | -40.0% |
| Net Margin | 9.9% | -19.6% |
| Revenue YoY | 2.6% | 3.8% |
| Net Profit YoY | -9.1% | -28.8% |
| EPS (diluted) | $1.41 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $649.1M | $384.8M | ||
| Q3 25 | $662.2M | $345.3M | ||
| Q2 25 | $613.6M | $355.8M | ||
| Q1 25 | $611.7M | $373.2M | ||
| Q4 24 | $632.4M | $370.7M | ||
| Q3 24 | $659.7M | $362.1M | ||
| Q2 24 | $647.8M | $379.2M | ||
| Q1 24 | $672.9M | $388.5M |
| Q4 25 | $64.4M | $-75.5M | ||
| Q3 25 | $43.6M | $-31.6M | ||
| Q2 25 | $-120.1M | $-20.4M | ||
| Q1 25 | $56.8M | $-20.5M | ||
| Q4 24 | $70.9M | $-58.6M | ||
| Q3 24 | $62.5M | $-46.5M | ||
| Q2 24 | $41.1M | $-12.0M | ||
| Q1 24 | $64.1M | $-18.7M |
| Q4 25 | 41.1% | — | ||
| Q3 25 | 41.7% | — | ||
| Q2 25 | 43.2% | — | ||
| Q1 25 | 41.2% | — | ||
| Q4 24 | 41.8% | — | ||
| Q3 24 | 39.9% | — | ||
| Q2 24 | 38.5% | — | ||
| Q1 24 | 40.2% | — |
| Q4 25 | 17.5% | -40.0% | ||
| Q3 25 | 18.0% | -12.8% | ||
| Q2 25 | -20.5% | -9.6% | ||
| Q1 25 | 16.5% | -10.2% | ||
| Q4 24 | 17.7% | -37.4% | ||
| Q3 24 | 16.9% | -29.5% | ||
| Q2 24 | 13.8% | -8.3% | ||
| Q1 24 | 16.9% | -11.3% |
| Q4 25 | 9.9% | -19.6% | ||
| Q3 25 | 6.6% | -9.1% | ||
| Q2 25 | -19.6% | -5.7% | ||
| Q1 25 | 9.3% | -5.5% | ||
| Q4 24 | 11.2% | -15.8% | ||
| Q3 24 | 9.5% | -12.8% | ||
| Q2 24 | 6.3% | -3.2% | ||
| Q1 24 | 9.5% | -4.8% |
| Q4 25 | $1.41 | $-23.08 | ||
| Q3 25 | $1.04 | $-9.67 | ||
| Q2 25 | $-2.65 | $-6.23 | ||
| Q1 25 | $1.21 | $-6.28 | ||
| Q4 24 | $1.49 | $-23.13 | ||
| Q3 24 | $1.29 | $-15.70 | ||
| Q2 24 | $0.84 | $-7.37 | ||
| Q1 24 | $1.28 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $95.3M | $25.0M |
| Total DebtLower is stronger | — | $228.4M |
| Stockholders' EquityBook value | $108.9M | $-155.2M |
| Total Assets | $2.1B | $656.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $25.0M | ||
| Q3 25 | $99.0M | $37.7M | ||
| Q2 25 | $107.3M | $38.6M | ||
| Q1 25 | $127.8M | $40.1M | ||
| Q4 24 | $152.0M | $38.8M | ||
| Q3 24 | $114.4M | $63.0M | ||
| Q2 24 | $133.5M | $73.1M | ||
| Q1 24 | $123.0M | $27.3M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | $1.5B | $182.0M | ||
| Q1 25 | $1.5B | $171.1M | ||
| Q4 24 | $1.5B | $108.9M | ||
| Q3 24 | $1.5B | $133.2M | ||
| Q2 24 | $1.5B | $133.1M | ||
| Q1 24 | $1.6B | $118.1M |
| Q4 25 | $108.9M | $-155.2M | ||
| Q3 25 | $74.0M | $-18.7M | ||
| Q2 25 | $63.9M | $44.5M | ||
| Q1 25 | $214.7M | $63.3M | ||
| Q4 24 | $227.8M | $75.9M | ||
| Q3 24 | $224.9M | $120.5M | ||
| Q2 24 | $223.5M | $166.8M | ||
| Q1 24 | $202.2M | $146.6M |
| Q4 25 | $2.1B | $656.6M | ||
| Q3 25 | $2.1B | $683.6M | ||
| Q2 25 | $2.1B | $731.6M | ||
| Q1 25 | $2.3B | $783.9M | ||
| Q4 24 | $2.3B | $783.4M | ||
| Q3 24 | $2.4B | $833.3M | ||
| Q2 24 | $2.4B | $892.8M | ||
| Q1 24 | $2.4B | $855.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 22.71× | 4.09× | ||
| Q1 25 | 7.16× | 2.71× | ||
| Q4 24 | 6.48× | 1.43× | ||
| Q3 24 | 6.78× | 1.11× | ||
| Q2 24 | 6.74× | 0.80× | ||
| Q1 24 | 7.84× | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $107.0M | $-25.7M |
| Free Cash FlowOCF − Capex | $99.3M | — |
| FCF MarginFCF / Revenue | 15.3% | — |
| Capex IntensityCapex / Revenue | 1.2% | — |
| Cash ConversionOCF / Net Profit | 1.66× | — |
| TTM Free Cash FlowTrailing 4 quarters | $278.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $107.0M | $-25.7M | ||
| Q3 25 | $75.0M | $-15.4M | ||
| Q2 25 | $123.1M | $-16.6M | ||
| Q1 25 | $16.5M | $-33.5M | ||
| Q4 24 | $142.9M | $-57.2M | ||
| Q3 24 | $72.1M | $-22.6M | ||
| Q2 24 | $122.1M | $-10.2M | ||
| Q1 24 | $39.8M | $-20.0M |
| Q4 25 | $99.3M | — | ||
| Q3 25 | $62.4M | — | ||
| Q2 25 | $114.4M | — | ||
| Q1 25 | $2.8M | — | ||
| Q4 24 | $125.5M | — | ||
| Q3 24 | $51.6M | — | ||
| Q2 24 | $107.5M | — | ||
| Q1 24 | $20.8M | — |
| Q4 25 | 15.3% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 18.6% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.6% | — | ||
| Q1 24 | 3.1% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 2.8% | 0.0% | ||
| Q3 24 | 3.1% | 0.0% | ||
| Q2 24 | 2.2% | 0.0% | ||
| Q1 24 | 2.8% | 0.0% |
| Q4 25 | 1.66× | — | ||
| Q3 25 | 1.72× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 2.02× | — | ||
| Q3 24 | 1.15× | — | ||
| Q2 24 | 2.97× | — | ||
| Q1 24 | 0.62× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GFF
| Consumer And Professional Products | $241.1M | 37% |
| Residential Repairand Remodel | $202.1M | 31% |
| International Excluding North America | $97.8M | 15% |
| Retail | $47.3M | 7% |
| Residential New Construction | $32.5M | 5% |
| Other | $14.2M | 2% |
| Industrial | $14.1M | 2% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
